United Kingdom · Pre-seed startup
Funding summaryUpdated 26 Oct 2026
$2.8Mraised across 4 rounds since 2024, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Angel Academe
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Respiratory Analytics filed 3 raises, $1.2M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Respiratory Analytics's own website: 3 founders.
AdvisersDr Jack Cochran
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Respiratory Analytics's investors include Angel Academe EIS Fund I, SyndicateRoom, QUBIS and The Amp Syndicate. Angel Academe EIS Fund I led its latest round.
Respiratory Analytics has raised $2.8M across 4 rounds since 2024.
Respiratory Analytics's most recent round was a Pre-seed of $1.6M in Oct 2026, led by Angel Academe EIS Fund I.
Its most recent round, $1.6M in Oct 2026, is also its largest on record.
Respiratory Analytics's first round on record, in Oct 2026, was backed by Angel Academe EIS Fund I, SyndicateRoom and QUBIS and 1 others.
Respiratory Analytics's latest named round is a Pre-seed, in Oct 2026.
Respiratory Analytics is based in the United Kingdom.
Angel Academe EIS Fund I led the Pre-seed in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
